BACE1 and Alzheimer disease: For instance, miR-206, targeting brain-derived neurotrophic factor (BDNF) and miR-29, targeting β-site amyloid precursor protein cleaving enzyme 1 (BACE1), were among the most addressed microRNA signatures of AD [41, 42].